Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03517917 · ClinicalTrials.gov registry record
Prospective Tissue Collection Research Protocol
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 221
- Enrollment target
NCT03517917 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 221 participants.
The verdict
NCT03517917 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 221 participants
- Enrollment target
Study Summary
This is a multi-solid tumour research study which collects tumour samples from patients alongside a matched whole blood, and/or leukapheresis product for the development of manufacturing processes for potential immunotherapies.
Interventions
- OTHER Tumour tissue collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2024-10-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03517917
The ClinicalTrials.gov registry entry for NCT03517917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumour tissue collection is the first listed.
NCT03517917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03517917 about?
NCT03517917 is a clinical study titled "Prospective Tissue Collection Research Protocol". This is a multi-solid tumour research study which collects tumour samples from patients alongside a matched whole blood, and/or leukapheresis product for the development of manufacturing processes for potential immunotherapies.
What is the current status of trial NCT03517917?
This trial is currently completed. The enrollment target is 221 participants. The study started on 2018-02-08. Estimated completion is 2024-10-08.
What interventions are being tested in trial NCT03517917?
The interventions under investigation include: Tumour tissue collection (OTHER).
Who is sponsoring clinical trial NCT03517917?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.